Patient Adherence to Evidence-Based Pharmacotherapy in Systolic Heart Failure and the Transition of Follow-Up from Specialized Heart Failure Outpatient Clinics to Primary Care
Anne Gjesing(Gentofte Hospital), Gunnar Gislason(Copenhagen University Hospital), Lars Videbæk(Odense University Hospital), Henrik Wiggers(Aarhus University), Morten Schou(British Heart Foundation), Finn Gustafsson(University of Copenhagen), Mette Charlot(Pediatric Nephrology of Alabama), Malene Nøhr Demant(Gentofte Hospital), Christian Torp‐Pedersen(University of Copenhagen), Lars Køber(University of Copenhagen), Per Hildebrandt(Frederiksberg Hospital)
Cited by 48
Related Papers
ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC
|European Heart Journal|2012|6.9k
Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction
|New England Journal of Medicine|2019|6.8k
Targeted Temperature Management at 33°C versus 36°C after Cardiac Arrest
|New England Journal of Medicine|2013|2.8k
ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012
|European Journal of Heart Failure|2012|2.6k
Valsartan, Captopril, or Both in Myocardial Infarction Complicated by Heart Failure, Left Ventricular Dysfunction, or Both
|New England Journal of Medicine|2003|2.5k